Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Ruplizumab (Anti-TNFSF5 / CD40L / CD154) For research use only.
Not for use in humans.

Ruplizumab (Anti-TNFSF5 / CD40L / CD154)

Synonyms: BG 9588

Ruplizumab (Anti-TNFSF5 / CD40L / CD154) is a humanized monoclonal antibody targeting CD40L(TNF Receptor). It has the potential for systemic lupus erythematosus disease research. MW :145.68 KD.

Ruplizumab (Anti-TNFSF5 / CD40L / CD154)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Ruplizumab (Anti-TNFSF5 / CD40L / CD154) is a humanized monoclonal antibody targeting CD40L(TNF Receptor). It has the potential for systemic lupus erythematosus disease research. MW :145.68 KD.

Product Details

CAS No. 220651-94-5
Isotype Human IgG1
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ruplizumab (Anti-TNFSF5 / CD40L / CD154) | Ruplizumab (Anti-TNFSF5 / CD40L / CD154) supplier | purchase Ruplizumab (Anti-TNFSF5 / CD40L / CD154) | Ruplizumab (Anti-TNFSF5 / CD40L / CD154) cost | Ruplizumab (Anti-TNFSF5 / CD40L / CD154) manufacturer | order Ruplizumab (Anti-TNFSF5 / CD40L / CD154) | Ruplizumab (Anti-TNFSF5 / CD40L / CD154) distributor